Works by Nakano, Takuji


Results: 14
    1
    2
    3

    Reduction of liver stiffness by antiviral therapy in chronic hepatitis B.

    Published in:
    Journal of Gastroenterology, 2011, v. 46, n. 11, p. 1324, doi. 10.1007/s00535-011-0444-4
    By:
    • Osakabe, Keisuke;
    • Ichino, Naohiro;
    • Nishikawa, Toru;
    • Sugiyama, Hiroko;
    • Kato, Miho;
    • Kitahara, Shiho;
    • Hashimoto, Senju;
    • Kawabe, Naoto;
    • Harata, Masao;
    • Nitta, Yoshifumi;
    • Murao, Michihito;
    • Nakano, Takuji;
    • Shimazaki, Hiroaki;
    • Arima, Yuko;
    • Suzuki, Koji;
    • Yoshioka, Kentaro
    Publication type:
    Article
    4
    5
    6
    7

    HLA-DQ gene polymorphisms are associated with hepatocellular carcinoma and hepatitis B surface antigen in chronic hepatitis B virus infection.

    Published in:
    Hepatology Research, 2017, v. 47, n. 8, p. 755, doi. 10.1111/hepr.12812
    By:
    • Ochi, Yuka;
    • Hashimoto, Senju;
    • Kawabe, Naoto;
    • Murao, Michihito;
    • Nakano, Takuji;
    • Kan, Toshiki;
    • Nakaoka, Kazunori;
    • Ohki, Masashi;
    • Kurashita, Takamitsu;
    • Takamura, Tomoki;
    • Nomura, Sayuri;
    • Nishikawa, Toru;
    • Fukui, Aiko;
    • Osakabe, Keisuke;
    • Ichino, Naohiro;
    • Yoshioka, Kentaro
    Publication type:
    Article
    8
    9
    10

    Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C.

    Published in:
    Hepatology Research, 2009, v. 39, n. 7, p. 675, doi. 10.1111/j.1872-034X.2009.00500.x
    By:
    • Nitta, Yoshifumi;
    • Kawabe, Naoto;
    • Hashimoto, Senju;
    • Harata, Masao;
    • Komura, Naruomi;
    • Kobayashi, Kyoko;
    • Arima, Yuko;
    • Shimazaki, Hiroaki;
    • Nakano, Takuji;
    • Murao, Michihito;
    • Ichino, Naohiro;
    • Osakabe, Keisuke;
    • Aoki, Hisako;
    • Hosoe, Yoko;
    • Sugiyama, Hiroko;
    • Nishikawa, Toru;
    • Yoshioka, Kentaro
    Publication type:
    Article
    11
    12
    13

    Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response.

    Published in:
    Current Oncology, 2024, v. 31, n. 10, p. 6218, doi. 10.3390/curroncol31100463
    By:
    • Kuzuya, Teiji;
    • Kawabe, Naoto;
    • Muto, Hisanori;
    • Tachi, Yoshihiko;
    • Ukai, Takeshi;
    • Wada, Yuryo;
    • Komura, Gakushi;
    • Nakano, Takuji;
    • Tanaka, Hiroyuki;
    • Nakaoka, Kazunori;
    • Ohno, Eizaburo;
    • Funasaka, Kohei;
    • Nagasaka, Mitsuo;
    • Miyahara, Ryoji;
    • Hirooka, Yoshiki
    Publication type:
    Article
    14

    Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma.

    Published in:
    Current Oncology, 2024, v. 31, n. 8, p. 4225, doi. 10.3390/curroncol31080315
    By:
    • Kuzuya, Teiji;
    • Kawabe, Naoto;
    • Muto, Hisanori;
    • Wada, Yuryo;
    • Komura, Gakushi;
    • Nakano, Takuji;
    • Tanaka, Hiroyuki;
    • Nakaoka, Kazunori;
    • Ohno, Eizaburo;
    • Funasaka, Kohei;
    • Nagasaka, Mitsuo;
    • Miyahara, Ryoji;
    • Hirooka, Yoshiki
    Publication type:
    Article